CTRI/2022/03/040774已完成2 期
preclinical and clinical evaluation of the effect on oral administration of POONAI MEESAI CHOORANAM KUDINEER in the management of OOTHU SOBAI
Dr P Narmatha1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年3月3日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- REDUCTION IN SYMPTOMS
研究概览
简要总结
It is single arm trails for preclinical and clinical evaluation of the effects on oral administration of poonai meesai chooranam kudineer in the management of oothu sobai
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 3.00 Year(s) 至 12.00 Year(s)（—）
- 性别
- All
入选标准
- •Oedema due to renal impairment.
排除标准
- •Children above 12 years Children below 3 years Hypothyroidism Cushing syndrome Oedema due to drug allergy Oedema mimics obesity in children Acute glomerular nephritis Chronic glomerular nephritis.
结局指标
主要结局
REDUCTION IN SYMPTOMS
时间窗: 21 days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Preclinical and clinical evaluation of the effect of Siddha classical drug PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER (oral administration ) along with PODI THIMIRTHAL ( external therapy) in the management of CHILDHOOD OBESITY.CTRI/2022/02/040297Dr J Mangalavalli40
已完成
1 期
A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941Liver DiseaseNCT01187186Astellas Pharma Inc16
已完成
1 期
A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy VolunteersHealthyNCT01002963Pfizer56
终止
1 期
RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy SubjectsHealthy VolunteersImpaired Renal FunctionNCT04252430MedDay Pharmaceuticals SA24
终止
1 期
HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy SubjectsHealthy VolunteersHepatic Impairment of Moderate Child Pugh CategoryNCT04252417MedDay Pharmaceuticals SA15